High Frequency Stimulation of the GPi or Thalamus in Tourette's Syndrome - Full Text View

High Frequency Stimulation of the GPi or Thalamus in Tourette's Syndrome

This study has been completed.

Sponsors and Collaborators:	Groupe Hospitalier Pitie-Salpetriere Institut National de la Santé Et de la Recherche Médicale, France
Information provided by:	Groupe Hospitalier Pitie-Salpetriere
ClinicalTrials.gov Identifier:	NCT00139308

Purpose

Tourette's syndrome is a disabling neuropsychiatric disorder with major psychosocial consequences in some patients. The pathophysiology is still unknown. Some data suggest an dysfunction of limbic circuits in basal ganglia. The aim of this study is to evaluate the effect of high frequency stimulation of the internal part of the globus pallidus and/or parafascicular-median centre of the thalamus, two structures implicated in the limbic circuit, in patients with severe Tourette's syndrome.

Condition	Intervention	Phase
Tourette's Syndrome	Device: high frequency stimulation	Phase I

Genetics Home Reference related topics:

familial encephalopathy with neuroserpin inclusion bodies familial paroxysmal nonkinesigenic dyskinesia Tourette syndrome

MedlinePlus related topics:

Tourette Syndrome

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Double-Blind, Placebo Control, Crossover Assignment, Safety/Efficacy Study

Official Title:	Pilot Study of Internal Globus Pallidus or Median Centre of the Thalamus High Frequency Stimulation for the Treatment of Patients With Severe Tourette's Syndrome

Further study details as provided by Groupe Hospitalier Pitie-Salpetriere:

Primary Outcome Measures:

Severity of tics

Eligibility

Ages Eligible for Study:	18 Years to 55 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Tourette's syndrome (DSM IV)
inducing a disability in the social and personal life
No improvement with medical treatment
Severe self suffering

Exclusion Criteria:

Cognitive impairment (MMS < 24)
Depression

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00139308

Locations


France
	Centre d'Investigation Clinique-Hôpital Pitié-Salpetriere
	Paris, France, 75013

Sponsors and Collaborators

Groupe Hospitalier Pitie-Salpetriere

Institut National de la Santé Et de la Recherche Médicale, France

Investigators


Study Director:	Yves Agid, MD, PhD	CIC-Pitié-Salpêtrière

More Information

Publications indexed to this study:

Welter ML, Mallet L, Houeto JL, Karachi C, Czernecki V, Cornu P, Navarro S, Pidoux B, Dormont D, Bardinet E, Yelnik J, Damier P, Agid Y. Internal pallidal and thalamic stimulation in patients with Tourette syndrome. Arch Neurol. 2008 Jul;65(7):952-7.

Study ID Numbers:	RBM0008
First Received:	August 30, 2005
Last Updated:	August 30, 2005
ClinicalTrials.gov Identifier:	NCT00139308
Health Authority:	France: Afssaps - French Health Products Safety Agency

Keywords provided by Groupe Hospitalier Pitie-Salpetriere:

Tourette's syndrome

High frequency stimulation

Globus pallidus

Thalamus

Study placed in the following topic categories:

Ganglion Cysts

Basal Ganglia Diseases

Central Nervous System Diseases

Tourette Syndrome

Tic Disorders

Brain Diseases

Neurodegenerative Diseases

Tics

Heredodegenerative Disorders, Nervous System

Genetic Diseases, Inborn

Movement Disorders

Mental Disorders

Mental Disorders Diagnosed in Childhood

Gilles de la Tourette's syndrome

Additional relevant MeSH terms:

Pathologic Processes

Disease

Syndrome

Nervous System Diseases

ClinicalTrials.gov processed this record on November 30, 2008